RAND tests whether AI agents can use biological design tools to evade DNA synthesis screening

arXiv · Research preprint

Read the source (opens in a new tab)
What happened
RAND's Center on AI, Security, and Technology posted a 48-page report on arXiv on October 2, 2026 testing frontier LLM agents on a biosecurity-relevant sequence redesign task.
Key points
  • The threat model is agents letting non-experts operate AI biological tools to evade nucleic acid synthesis screening, which the report calls "a critical early defensive layer" against biological misuse.
  • It finds agents show an emerging ability to use these tools, and that some agent-redesigned sequences evaded screening measures in place at some major commercial synthesis providers.
  • Reliability was mixed: the agents were "not able to carry out our task with high reliability," and failures appeared at several points rather than one.
  • Refusals and content filters blocked the newest Anthropic and OpenAI models, so the tested models likely do not show the capability ceiling; for open-weight models safeguards "generally did not prevent misuse."
Evidence
RAND research report, quality-assured by RAND and posted to arXiv; it cites an earlier RAND report on whether agents can select and engage biological tools. The results come from computational tests, not laboratory work.
Uncertain
RAND says success rates are likely influenced by environmental particulars, and that it is unclear how far provider refusals and filters would stop a motivated threat actor.

See it in the latest record